中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (2): 127-133.doi: 10.35541/cjd.20220857

• 论著 • 上一篇    下一篇

玫瑰痤疮真实世界诊疗现状调查分析

那君1,2    李若瑜1    仲少敏1    杨莉   吴艳1   

  1. 1北京大学第一医院皮肤科  北京市皮肤病分子诊断重点实验室  国家皮肤与免疫疾病临床医学研究中心,北京  100034;2天津医科大学总医院皮肤科,天津  300052
  • 收稿日期:2022-12-02 修回日期:2023-12-11 发布日期:2024-02-01
  • 通讯作者: 吴艳 E-mail:3437477565@qq.com
  • 基金资助:
    国家重点研发计划项目(2021YFF1201104)

Diagnosis and treatment of rosacea in the real world: a survey on the current status

Na Jun1,2, Li Ruoyu1, Zhong Shaomin1, Yang Li1, Wu Yan1   

  1. 1Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, Beijing 100034, China; 2Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, China
  • Received:2022-12-02 Revised:2023-12-11 Published:2024-02-01
  • Contact: Wu Yan E-mail:3437477565@qq.com
  • Supported by:
    National Key R&D Program of China(2021YFF1201104)

摘要: 【摘要】 目的 分析我国玫瑰痤疮的诊疗现状,加强对疾病的认知和管理。方法 采用回顾性横断面研究,纳入南北方6个省或直辖市23家三级医院的玫瑰痤疮患者,以问卷调查的方式收集患者的临床特征、既往诊断和治疗情况。非正态分布的连续变量以M(Q1,Q3)表示,比较采用Mann-Whitney U检验。分类变量比较采用χ2检验。结果 593例玫瑰痤疮患者中,男164例,女429例,男女比例1∶2.6;来自南方205例,北方388例;20 ~ 40岁最常见(349例,58.8%),北方地区就诊患者的中位年龄(37岁)显著大于南方(30岁,P < 0.001)。患者中常见多部位受累(371例,62.6%)和多种表型共存(391例,65.9%),面颊(429例,72.3%)和鼻部(393例,66.3%)最易受累,皮疹以持续性红斑(354例,59.7%)、丘疹脓疱(344例,58.0%)、毛细血管扩张(282例,47.6%)多见。南方患者(160例,78.0%)面颊部受累较北方患者(269例,69.3%)更多见,但鼻部(南方:125例,61.0%;北方:268例,69.1%)和眼部(南方:3例,1.5%;北方:23例,5.9%)受累少见(均P < 0.05)。南方患者一过性红斑(38.0%)和丘疹脓疱发生率(65.4%)均较北方高(分别为20.9%和54.1%),而北方患者更多表现为持续性红斑(南方49.8%,北方64.9%;均P < 0.05)。玫瑰痤疮患者病程M(Q1,Q3)为12(4,30)个月,从发病到诊断时间10(3,24)个月,北方患者病程[12(4,36)个月]及 > 5年患者比例(63例,16.4%)均高于南方[12(3,24)个月;19例,9.4%;均P < 0.05]。不同亚型及严重程度的患者既往以外用抗微生物药物为主(使用率71.9%);轻症患者系统用药率达72.7%;患者依从性差,单次治疗4周以上者仅占40.6%。结论 我国玫瑰痤疮好发于中青年,面颊及鼻部最易受累,以红斑或丘疹脓疱多见。在临床诊疗中存在诊断延迟、药物治疗不规范、患者依从性差等问题。

关键词: 红斑痤疮, 皮肤表现, 延迟诊断, 药物疗法, 流行病学, 地域性, 真实世界

Abstract: 【Abstract】 Objective To analyze the current status of diagnosis and treatment of rosacea in China, and to strengthen the understanding and management of this disease. Methods A retrospective cross-sectional study was conducted, and patients with rosacea were enrolled from 23 tertiary hospitals in 6 provinces or municipalities in northern and southern China. Clinical characteristics, previous diagnosis and treatment status of these patients were collected through questionnaires. Non-normally distributed continuous data were described by M (Q1 , Q3), and compared using Mann-Whitney U test, while categorical data were compared using chi-square test. Results Among the 593 patients with rosacea, 164 were males and 429 were females, with a male-to-female ratio of 1∶2.6; 205 patients were from southern China, and 388 from northern China; most patients (349 cases, 58.8%) were aged 20 to 40 years, and the patients from northern China were significantly older than those from southern China (median age: 37 years vs. 30 years, P < 0.001). Multiple-site involvement (371 cases, 62.6%) and coexistence of multiple phenotypes (391 cases, 65.9%) were common, the cheeks (429 cases, 72.3%) and nose (393 cases, 66.3%) were mostly affected, and skin lesions mainly manifested as persistent erythema (354 cases, 59.7%), papulopustules (344 cases, 58.0%), and telangiectasia (282 cases, 47.6%). Involvement of the cheeks was more common in the patients from southern China (160 cases, 78.0%) than in those from northern China (269 cases, 69.3%), but the nose and eyes were less involved in the patients from southern China than in those from northern China (nose: 125 cases [61.0%] vs. 268 cases [69.1%]; eyes: 3 cases [1.5%] vs. 23 cases [5.9%]; both P < 0.05). The prevalence of transient erythema and papulopustules was significantly higher in the patients from southern China (38.0% and 65.4%, respectively) than in those from northern China (20.9% and 54.1% respectively, both P < 0.05), while the patients from northern China more frequently presented with persistent erythema compared with those from southern China (64.9% vs. 49.8%, P < 0.05). The disease duration (M [Q1 , Q3]) was 12 (4, 30) months among the patients with rosacea, and the time from the onset to diagnosis was 10 (3, 24) months. The disease duration was significantly longer (12 [4, 36] months), and the proportion of patients with disease duration > 5 years was significantly higher (16.4% [63 cases]) in the patients from northern China than in those from southern China (12 [3, 24] months, 9.4% [19 cases], respectively; both P < 0.05). The patients with varied subtypes and severity of rosacea were previously mainly treated with topical antimicrobial agents (71.9%); 72.7% of the patients with mild rosacea were treated with systemic drugs; poor patient compliance was observed, and only 40.6% of the patients completed more than 4 consecutive weeks of treatment at a time. Conclusions Rosacea usually occurred in young and middle-aged people in China, mostly involved the cheeks and nose, and mainly manifested as erythema or papulopustules. Delayed diagnosis, non-standard treatment and poor patient compliance existed in clinical practice.

Key words: Rosacea, Skin manifestations, Delayed diagnosis, Drug therapy, Epidemiology, Regionality, Real world

引用本文

那君 李若瑜 仲少敏 杨莉 吴艳. 玫瑰痤疮真实世界诊疗现状调查分析[J]. 中华皮肤科杂志, 2024,57(2):127-133. doi:10.35541/cjd.20220857

Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status[J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133.doi:10.35541/cjd.20220857